Video & Transcript : 'FDA user fees' :

Page 5 of 500
TX

Texas 89th Regular

Pensions, Investments & Financial Services Apr 14th, 2025

Pensions, Investments & Financial Services

TX
CA

California 2025-2026 Regular Session

Assembly Environmental Safety and Toxic Materials Committee Apr 14th, 2026

Environmental Safety and Toxic Materials

Transcript Highlights:
  • The FDA is not on top of this issue.
  • submission to FDA of GRAS notices. ...a proposed regulation to require the submission to FDA of GRAS
  • And indeed, the FDA... products are safe.
  • FDA is still in the process of determining action levels for heavy metals and FDA is still in the process
  • And so the FDA is now... But I'm a grandmom.
AZ

Arizona 2026 Regular Session

02/11/2026 - House Ways & Means

Ways & Means

Transcript Highlights:
  • It's a moratorium on increases in taxes and fees.
  • And so what we're trying to accomplish with this moratorium on tax and fee increases...
  • They largely subsidize those user fee functions with general fund money, so please know that fees will
  • General funds are critical for services that cannot be supported by user fees, public safety, parks,
  • community as we needed to institute a wastewater capacity fee this past year.
Bills: HB2780 , HB4029 , HB4030 , HCR2052
WA
Transcript Highlights:
  • And importantly, it exempts EBT users, recognizing the affordability element.
  • I’ll also note that it puts a lot of onus on the retailer to enforce the fees.
  • More than doubling the fee on paper does not meaningfully encourage reuse.
  • We would also like to note that the plastic bag fee increased to 12 cents.
  • Thank you so much for your testimony. ...place a fee on a competing commodity.
Summary: The committee held public hearings on several bills, beginning with SB 5965 on retail bags. Staff explained that the bill would prohibit single-use plastic and reusable film plastic carryout bags, raise the paper bag pass-through charge from 8 cents to 20 cents, exempt certain assistance-program customers from bag charges, and add manufacturer/distributor penalties. The sponsor and supporters, including environmental groups, Seattle Public Utilities, Tacoma, county solid waste representatives, and health advocates, argued the current law has led to thicker plastic bags and more plastic pollution, microplastics, and recycling contamination. Opponents from hospitality, grocery, retail, paper, and plastic bag industries said the bill would raise costs, create checkout confusion, burden food delivery and takeout operations, and amount to a de facto ban on paper bags as well; several urged waiting for more data on the current 12-cent fee. The hearing ended with a reported 1,240 non-testifiers on SB 5965, with 541 pro, 695 con, and 4 other. The committee then heard SB 6030 on plastic bags. Staff said the bill would allow film plastic and paper carryout bags if they meet recycled-content standards, keep the paper bag fee at 8 cents, reduce the plastic bag fee from 12 cents to 8 cents, and remove the minimum thickness standards for reusable film plastic bags while retaining recycled-content requirements and the SNAP exemption. No public testimony was taken on the bill, and the chair noted 208 non-testifiers, with 192 pro, 11 con, and 5 other. Finally, the committee heard SB 5975 on lead in cookware. Staff described it as a third-round update to the state’s cookware lead law, narrowing covered cookware, delaying the 10 ppm lead standard to 2030, and allowing compliance through FDA or European testing methods. Supporters, including some industry representatives, said the current law is unclear and difficult to enforce, that a workable test is still being developed, and that the bill would provide certainty and avoid unintended coverage of safe products. Opponents from Ecology, Health, environmental groups, and consumer advocates argued the bill would weaken Washington’s existing protections, create broad exemptions, and allow high-lead cookware to remain on the market; they also criticized shifting from total-content testing to leach testing. The hearing closed with 609 non-testifiers on SB 5975, with 54 pro and 552 con.
TX

Texas 89th Regular

Natural Resources May 21st, 2025

Natural Resources

Transcript Highlights:
  • Senate Bill 612 is to prevent water districts from charging excessive pipeline construction fees to developers
  • Water districts in the region have, in some cases, used arbitrary fee schedules and overly strict construction
  • requirements to extract fees from developers far beyond actual costs.
  • This prohibits the water districts from imposing on developers fees greater than the actual reasonable
Bills: SB612 , SB1855 , SB2568 , SB3058 , HB49
CA
Transcript Highlights:
  • And then I'm concerned about the end user.
  • The FDA is not on top of this issue.
  • submission to FDA of GRAS notices.
  • to FDA of GRAS notices.
  • And so the FDA is now... But I'm a grandmom.
Summary: The committee heard AB 1795, which would create statewide standards for testing, inspection, remediation, and insurance handling of wildfire smoke damage in homes. The author and Insurance Commissioner Ricardo Lara said the bill is needed because survivors face inconsistent claims practices and no enforceable standards for determining when homes are safe. Supporters included the City of Los Angeles and a wildfire survivor who described health problems and disputed remediation results; opponents from the insurance industry said the bill could create broad new exposure and worsen affordability, though they continued to negotiate amendments. The committee recommended the bill do pass with urgency, and it passed on a 4-0 vote, with the roll held open for additional votes. The committee also heard AB 1612, which would create a centralized process for law enforcement to transfer seized controlled substances such as fentanyl, methamphetamine, and heroin to the Department of Justice for disposal after the state’s last in-state incineration facility closed. The author said the bill would address unsafe storage and inconsistent disposal pathways. There was no opposition in the room, and the committee sent the bill to the Assembly Public Safety Committee on a do pass vote. AB 2322 would standardize the definition of commercial, industrial, or institutional sites for municipal stormwater permits by tying it to assessor land-use codes and excluding residential parcels. Supporters said the bill would reduce patchwork enforcement and improve consistency, while stormwater and city representatives asked to keep working on regional flexibility concerns. The committee approved the bill 4-1 and sent it to Appropriations. The committee then heard AB 2245, a producer responsibility bill for vehicle lubricant products and their containers, intended to expand collection and recycling using existing household hazardous waste and used oil infrastructure. Supporters said it would reduce landfill disposal and align with existing EPR frameworks, while retailers and industry groups raised concerns about overlapping obligations, unclear definitions, and compliance costs. The author said negotiations would continue, and the committee sent the bill to Natural Resources on a do pass vote. The committee also heard AB 1603, which would phase out PFAS-containing pesticides over time and require disclosure and permitting for their use. Supporters argued PFAS pesticides contaminate food and water and pose health risks; agricultural and chemical industry opponents said the bill could remove many products from the market and lead to harmful substitutions. The chair expressed support for reducing PFAS but raised concerns about replacement chemicals, and the bill was sent to Appropriations on a do pass vote. Finally, AB 2034 was introduced to increase transparency around food additives and GRAS ingredients by creating a state database of chemicals that bypass FDA premarket review; supporters said it would close a federal loophole, while consumer brands opposed a duplicative state system and warned of costs and confusion.
NM

New Mexico 2026 Regular Session

Senate - Conservation Jan 31st, 2026 at 09:07 am

Senate Conservation

Transcript Highlights:
  • Update certain agricultural fees. Senate Bill 143.
  • In some instances, fee caps have not been addressed in 50 or more years.
  • Is this a renewal fee as well? Farms or the ranches.
  • rulemaking in the future to raise that fee in rule.
  • It does not necessarily raise the fees.
Bills: SB47 , SB110 , SB122 , SB143 , SB168
TX
Transcript Highlights:
  • Most long-term marijuana users develop insomnia, and of course, long-term users...
  • Studies show one in 10 users become dependent.
  • Induced psychosis is a significant issue because users, and even former users, often don't realize they
  • , and $20,000 for annual fees.
  • These fees are the norm in both blue and red cannabis legal states, except those state fees are actually
Bills: SB5 , SB11 , SB12 , SB 5 , SB 11 , SB 12
CA

California 2025-2026 Regular Session

Assembly Business and Professions Committee Apr 14th, 2026

Business and Professions

Transcript Highlights:
  • And they contradict the FDA.
  • FDA-approved.
  • And the good news is that the FDA is starting to act.
  • Has the FDA weighed in on the formulation for the adding?
  • But FDA is starting to get serious, particularly about advertising.
FL

Florida 2025 Regular Session

February 4, 2025 - 12:30 PM

Transcript Highlights:
  • This is an open-access journal, so it's available without fees.
  • We participated, or we collaborated with the FDA last year, in an evidence synthesis.
  • So we use the same methods that the FDA is using and classifying these reports.
  • So this is focused specifically on long-term opioid users and opioid-sparing effects.
  • So this is focused specifically on long-term opioid users and opioid sparing effects.
Summary: The Health Professions and Program Subcommittee met to receive oversight briefings on Florida’s medical marijuana program from the Department of Health’s Office of Medical Marijuana Use (OMMU) and from the University of Florida’s Consortium for Medical Marijuana Clinical Outcomes Research. OMMU Director Christopher Kimball outlined the program’s structure, including more than 900,000 active patients, nearly 7,000 caregivers, 27 MMTC licensees, 706 dispensing locations, and nine certified testing labs. He described the state’s pre-approval process for products and advertising, plain packaging requirements, seed-to-sale tracking, registry operations, and compliance efforts such as background checks, inspections, complaint investigations, and lab desk audits. He also said the Bureau of Public Health Laboratories in Jacksonville had been accredited to begin supporting testing. Members asked about telehealth, patient growth, product safety, advertising to children, inspections, and the status of MMTC licensure; Kimball said recertifications by telehealth now make up more than half of recertifications, that patient growth has slowed, and that ongoing litigation is delaying issuance of 22 new MMTC licenses. Kimball also discussed implementation of recent legislation and licensure changes, including licenses issued under HB 387 and SB 1582 to applicants from the original Pigford-related pool, with additional cure opportunities still ongoing. He said the department is monitoring diversion, inversion, and unapproved products, and that it coordinates with law enforcement when needed but does not itself have sworn authority. In response to questions, he said the department does not regulate physicians directly, but may refer concerns to the Division of Medical Quality Assurance, and that caregiver and physician participation requirements are set by statute. Members raised concerns about edibles, child access, and continued use of child-attractive branding; Kimball said the department tries to catch issues through pre-approval and enforcement, and that complaints involving children are treated as serious and investigated using available records and camera footage. Dr. Almond Winterstein then presented the consortium’s research overview. He explained that the consortium was created by statute in 2019, includes 10 universities, and is funded by annual state appropriations. He said its work includes grants, a research repository, a clinical core, outreach, and evidence synthesis, including a recent FDA-supported review of cannabis evidence. He emphasized that the current evidence base is limited and often low quality, with the strongest signals for symptom relief in PTSD-related symptoms, nausea, and some pain outcomes, but with many studies inconclusive or mixed. He also described the consortium’s use of registry data linked to Medicaid, Medicare, death, fetal death, and birth records to study safety and outcomes, including children, pregnancy, driving safety, opioid-sparing effects, and adverse events. Winterstein said adverse event reporting is sparse and likely underreported, with most reports mild but some serious events noted, and he expressed concern about use among young adults because of uncertain benefit-risk and possible effects on the developing brain. The committee discussed the need for better surveillance, more robust adverse event reporting, and the possibility of using linked data to identify harms more quickly. At the end of the meeting, the committee rose without objection.
MN

Minnesota 2025-2026 Regular Session

House Commerce Finance and Policy Committee 3/12/25

Commerce Finance and Policy

Transcript Highlights:
  • This proposal will align Minnesota with over 40 states that do not have fee restrictions in excess of
  • </c><00:07:29.759><c> restrictions</c><00:07:30.680><c> in</c> do not have Fe fee restrictions in do
  • The fees are enormous.
  • So the fees that you pay on a monthly basis will vary greatly between associations.
  • Second is the costs that are built into an HOA as a monthly association fee assessment.
Bills: HF1865 , HF2014 , HF2028
AZ

Arizona 2026 Regular Session

02/04/2026 - House Judiciary

Judiciary

Transcript Highlights:
  • There are other fees that this bill addresses, like the right to a fee for appeal, and in my view, we
  • In Arizona, however, there is a fee for some of these and the ability to charge a fee for others.
  • However, there is a fee for some of these and the ability to charge a fee for others.
  • This bill removes that fee and blocks future fees on any constitutional rights that we have.
  • collection of the fees.
DE

Delaware 2025-2026 Regular Session

Senate Health & Social Services Committee Meeting Jun 24th, 2026

Health & Social Services

Transcript Highlights:
  • The FDA evaluated over 965 reports...
  • The FDA evaluated over 965 reports of harm, including 264 deaths.
  • I have been a natural kratom user for about nine years now.
  • I'd also like to mention that even melatonin is not FDA approved because the FDA does not approve supplements
  • FDA director without kratom and 7-OH.
Bills: HB305 , HB395 , HB341
Summary: The committee met in late June with Senators Hansen, Buckson, Siegfried, Townsend, and Huxable present, and first approved the meeting minutes by voice vote. The opening bill, HB 341, would limit DFS from filing child support in foster care cases unless doing so would not hinder reunification; Children’s Department staff said the department has already decided to stop filing in all such cases, with an estimated fiscal impact of about $140,000 annually. Public testimony from the League of Women Voters supported the bill as a compassionate measure to help families reunite. The committee then heard HB 446/related anaphylaxis legislation for colleges and universities, which would allow institutions to stock and use intranasal epinephrine alongside auto-injectors and update training and reporting requirements. The Asthma and Allergy Foundation of America supported the measure, emphasizing the need for needle-free options and faster treatment of anaphylaxis. The committee also took up HS1 for HB 356 on PFAS, which would ban firefighting foam containing PFAS beginning in 2028, require disclosure if PPE contains PFAS, and address recalls; DNREC and the fire service supported it, saying most departments have already transitioned away from PFAS foam. A major portion of the meeting focused on HB 305, a diabetes wellness pilot program that would use continuous glucose monitoring, app-based care coordination, lab testing, and DHIN data analysis to shift care toward prevention and remission. Sponsor Senator Siegfried described the bill as a response to Delaware’s high diabetes costs and prevalence, and the Medical Society of Delaware supported it as a proactive model. The committee also discussed HB 395, which would regulate intoxicating hemp-derived products and synthetic cannabinoids by classifying products over a THC threshold as marijuana and creating penalties for unlicensed sales; the Office of the Marijuana Commissioner supported the bill, while hemp industry representatives and Senator Hoffner warned it could harm legitimate hemp retailers and access to hemp products. The final item, HS1 for HB 332, would ban sales and marketing of kratom products to those under 21 and direct the state to study testing and regulation of kratom and synthetic variants. Supporters, including the Delaware Healthcare Association and several recovery advocates, said age-gating is a reasonable first step and that synthetic products are the main concern; opponents and some senators argued the bill should go further and fully ban kratom or better distinguish synthetic products from natural leaf kratom. No formal roll-call votes were taken on the substantive bills during the transcript, and the meeting adjourned after public comment.
NM

New Mexico 2026 Regular Session

House - Health and Human Services Feb 6th, 2026 at 08:33 am

House Health & Human Services

Transcript Highlights:
  • Livanova, the manufacturer of the vagal nerve simulator, as approved by the FDA.
  • According to the Medicaid fee schedule, the effective date was January 1, 2015.
  • And until those are FDA approved, they're considered an off-label use, as you know.
  • In our FIR, it says that they are reimbursed at 100% of the Medicare fee schedule.
  • Actually, Representative, we are paying 150% of the Medicare fee schedule.